Stock market crash: I’d buy these cheap shares for their 6.1% dividend yield!

As the FTSE 100 suffers one of its worst days since the March meltdown, these cheap shares have become crazily mispriced. I’d happily buy more today.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today has been a bad day for the FTSE 100 index. It is suffering one of its biggest dives since the March market meltdown. As I write, the Footsie hovers around 5,543, down over 185 points (3.3%) late on Wednesday. Thus, the FTSE 100 has lost almost 950 points (14.6%) since its post-crash peak of 6,484 on 5 June. Perhaps the only good news for value investors is that falling stock prices are pushing stocks deeper into the ‘cheap shares’ bargain bin.

These cheap shares just keep falling

Take, for example, shares of UK pharmaceutical giant GlaxoSmithKline (LSE: GSK), whose stock seems to be in permanent decline nowadays. GSK is not only my largest single shareholding, I’ve also owned its shares for pretty much all of the past 30 years.

Yet these cheap shares seem to be in a downward death spiral of late. Earlier this year, before Covid-19 wreaked havoc worldwide, GSK shares hit a 52-week high of 1,857p on 24 January. Then, as the global pandemic escalated, the share price crashed to close below 1,375p on 23 March. It then bounced back with the wider FTSE 100, hitting a post-crash high of 1,742p by 13 May. Ever since, it’s been on a decline. As I write, GSK shares trade around 1,308p, down 3.9% in a single day and now 67p (almost 5%) below their March low. Ouch.

GSK’s share price slipped again today

GSK stock was on the rise until noon, when the company released its latest quarterly results. GSK reported a 3% decline in quarterly revenues to £8.6bn (£0.2bn below analysts’ estimates). However, the UK pharma giant’s adjusted earnings per share rose by 1%, hitting 35.6p and beating the forecast 30.4p. This suggests that these cheap shares are trading on a modest price-to-earnings ratio of 10 or below.

Within the results was the good news that three new products have been approved since the second quarter. Also, sales at its core vaccines division were returning to normal, after being suppressed by lockdowns preventing vaccination campaigns. Another piece of good news was the decline in net debt to £23.9bn, down £1.2bn from £25.2bn at the end of 2019. Yet these cheap shares have collapsed by roughly a quarter (25%) over the past 12 months.

For me, GSK’s cheap shares are a bargain buy

Often, and especially at this time, being a committed value investor can be painful. Cheap shares in companies with strong balance sheets, lowly rated earnings and high dividend yields are being shunned by other investors. I absolutely understand why many buyers prefer to stick with exciting, momentum-driven growth shares such as US tech stocks. Yet the ever-widening gap between growth and value shares can only go so far before it snaps back towards sensible levels.

Perhaps the only good news today for existing GSK shareholders is that these cheap shares pay a delicious dividend. GSK confirmed the latest quarterly cash dividend per share at the usual 19p level, with 80p on the cards for the full year. At the current share price, this works out to a dividend yield of 6.1%, which should be irresistible to income seekers. What’s more, with GSK’s earnings per share for three quarters totalling 102p, this dividend will be comfortably covered by 2020’s total earnings.

In summary, with the stock at its lowest level since February 2018, 2020 has been cruel for GSK shareholders. That said, I’d happily buy these cheap shares today, ideally inside an ISA, to enjoy a juicy tax-free passive income to retire rich. And for future capital gains when this great British business returns to growth!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »